Glycemic Velocity and Early Retinal Microvascular Change With GLP-1RA Versus SGLT2i Initiation in Type 2 Diabetes (GLIDE)

NCT07723820 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

126

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Diabetic Retinopathy (DR)

Interventions

DRUG: GLP-1 Receptor Agonists
DRUG: SGLT2 inhibitor

Sponsor

Thammasat University Hospital

Collaborators

[object Object]